Call Options

19 transactions
Quarter Operation Price Per call calls change calls Held SEC Form
Q3 2024

Nov 14, 2024

BUY
$0.54 - $0.92 $1,188 - $2,024
2,200 Added 15.07%
16,800 $10,000
Q2 2024

Aug 15, 2024

BUY
$1.0 - $1.45 $4,500 - $6,525
4,500 Added 44.55%
14,600 $14,000
Q1 2024

May 07, 2024

SELL
$1.02 - $3.23 $28,764 - $91,086
-28,200 Reduced 73.63%
10,100 $12,000
Q4 2023

Feb 14, 2024

BUY
$1.72 - $3.18 $65,876 - $121,794
38,300 New
38,300 $104,000
Q2 2023

Aug 11, 2023

BUY
$3.6 - $5.25 $38,880 - $56,700
10,800 New
10,800 $47,000
Q4 2022

Feb 14, 2023

SELL
$5.66 - $8.42 $670,710 - $997,770
-118,500 Reduced 46.33%
137,300 $1.16 Million
Q3 2022

Nov 14, 2022

BUY
$3.02 - $6.12 $671,950 - $1.36 Million
222,500 Added 668.17%
255,800 $1.57 Million
Q2 2022

Aug 15, 2022

SELL
$2.6 - $6.14 $64,480 - $152,272
-24,800 Reduced 42.69%
33,300 $104,000
Q1 2022

May 16, 2022

SELL
$5.08 - $9.81 $1.52 Million - $2.93 Million
-298,800 Reduced 83.72%
58,100 $331,000
Q4 2021

Feb 14, 2022

BUY
$8.55 - $111.89 $2.89 Million - $37.8 Million
338,100 Added 1798.4%
356,900 $3.49 Million
Q3 2021

Nov 15, 2021

SELL
$76.53 - $110.43 $145,407 - $209,817
-1,900 Reduced 9.18%
18,800 $1.99 Million
Q2 2021

Aug 11, 2021

BUY
$85.37 - $114.1 $315,869 - $422,170
3,700 Added 21.76%
20,700 $1.77 Million
Q1 2021

May 17, 2021

SELL
$109.73 - $153.66 $2.83 Million - $3.96 Million
-25,800 Reduced 60.28%
17,000 $1.95 Million
Q4 2020

Feb 16, 2021

BUY
$79.58 - $152.45 $1.06 Million - $2.03 Million
13,300 Added 45.08%
42,800 $5.99 Million
Q3 2020

Nov 16, 2020

SELL
$66.43 - $90.99 $1.55 Million - $2.12 Million
-23,300 Reduced 44.13%
29,500 $2.4 Million
Q2 2020

Aug 14, 2020

BUY
$44.04 - $80.69 $717,852 - $1.32 Million
16,300 Added 44.66%
52,800 $3.79 Million
Q1 2020

May 15, 2020

SELL
$44.49 - $93.39 $4.14 Million - $8.69 Million
-93,100 Reduced 71.84%
36,500 $1.62 Million
Q4 2019

Feb 14, 2020

BUY
$66.49 - $137.73 $4.99 Million - $10.3 Million
75,100 Added 137.8%
129,600 $12.4 Million
Q3 2019

Nov 14, 2019

BUY
$31.0 - $89.73 $1.69 Million - $4.89 Million
54,500 New
54,500 $4.29 Million

Others Institutions Holding ALLK

About Allakos Inc.


  • Ticker ALLK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 84,726,096
  • Market Cap $79.6M
  • Description
  • Allakos Inc., a clinical stage biopharmaceutical company, develops therapeutics that target immunomodulatory receptors present on immune effector cells in allergy, inflammatory, and proliferative diseases. The company's lead monoclonal antibody is lirentelimab (AK002), which is in a Phase III study for the treatment of eosinophilic gastritis and...
More about ALLK
Track This Portfolio

Track Susquehanna International Group, LLP Portfolio

Follow Susquehanna International Group, LLP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

News

Stay updated on Susquehanna International Group, LLP with notifications on news.